March 17, 2025
New research suggests clinicians should warn patients about the potential of cannabis to harm cardiovascular health. But how big a risk cannabis presents depends on the […]
March 14, 2025
Edited By: Manasi Talwadekar TOPLINE: Cardiovascular risk factors and comorbidities are prevalent among asymptomatic aircraft pilots referred for medical screening, but these individuals generally represent a healthy […]
March 13, 2025
FLORENCE, Italy — Should anticoagulant therapy be discontinued or continued in patients with unprovoked deep vein thrombosis (DVT)? This question was at the center of a […]
March 13, 2025
Guidelines for the management of atrial fibrillation in different parts of the world are largely in agreement on how to handle the condition, but differences can […]
March 13, 2025
An ribonucleic acid (RNA) inhibitor, olpasiran (Amgen), which has shown it can lower lipoprotein(a) [Lp(a)] levels in patients with cardiovascular disease (CVD), has demonstrated in a […]
March 12, 2025
Lorundrostat, a hypertension drug from Mineralys Therapeutics, has shown positive results in two pivotal trials for the treatment of uncontrolled or resistant hypertension the company announced […]
March 12, 2025
While conducting the CLEAR SYNERGY (OASIS 9) trial, lead author Sanjit Jolly, MD continued to treat some of his patients post–myocardial infarction (MI), including his late […]
March 11, 2025
TOPLINE: Integration of pre- and postablation B-type natriuretic peptide (BNP) levels in patients with persistent atrial fibrillation (AF) facilitated risk stratification for major adverse cardiovascular events […]
March 11, 2025
TOPLINE: A 12-week supervised high-intensity exercise programme was feasible for patients with hypertrophic cardiomyopathy (HCM), leading to potential improvements in cardiorespiratory fitness, cardiovascular risk factors, and […]